SecBot SecBot
SECBOTREPLAY Home › Report › IONS

IONS · TRYNGOLZA guide cut to ~$50M

IONIS PHARMACEUTICALS INC · 8-K filed Nov 9, 2026 at 07:00 ET

At the news

BEARISHIMPACT 6/10

8-K filed Nov 9, 2026 at 07:00 ET

Total revenue, DAWNZERA guidance, operating loss and cash guidance were reaffirmed.

  • TRYNGOLZA 2026 product sales guidance lowered to ~$50M from $100-110M
  • DAWNZERA 2026 product sales guidance reaffirmed at $110-120M
  • Total revenue guidance reaffirmed at $875-900M
  • Cash and short-term investments $1.9B as of Sep 30, 2026

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access